Chemical Property of 1-[5-Ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-YL)heptyl]oxy]phenyl]ethanone
Chemical Property:
- Vapor Pressure:9.45E-14mmHg at 25°C
- Melting Point:160-162 °C
- Boiling Point:573.4°Cat760mmHg
- PKA:5.11±0.10(Predicted)
- Flash Point:300.6°C
- PSA:100.99000
- Density:1.157g/cm3
- LogP:3.58730
- Storage Temp.:Store at +4°C
- Solubility.:DMSO: >20mg/mL
- XLogP3:4.6
- Hydrogen Bond Donor Count:2
- Hydrogen Bond Acceptor Count:6
- Rotatable Bond Count:10
- Exact Mass:360.21614077
- Heavy Atom Count:26
- Complexity:447
- Purity/Quality:
-
98%min *data from raw suppliers
LY 255283 *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CCC1=CC(=C(C=C1OCCCCCC(C)(C)C2=NNN=N2)O)C(=O)C
-
Description
Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years. The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM. LY255283 exhibits IC50 values of ~950 nM and >10 μM at human recombinant BLT2 and BLT1 receptors, respectively. LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 μM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.
-
Uses
LY-255283 is a selective, competitive BLT2 receptor antagonist used in the treatment of chronic myeloid leukemia.